These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1799920)

  • 1. Impact of transfer from animal-source insulins to biosynthetic human insulin (rDNA E coli) in patients with diabetes mellitus.
    Garber AJ; Davidson JA; Krosnick A; Beaser RS; Anderson JH
    Clin Ther; 1991; 13(5):627-36. PubMed ID: 1799920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
    Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indication of intensive insulin therapy and its practice].
    Kishikawa H; Taguchi T; Matsumoto K; Shichiri M
    Nihon Rinsho; 1999 Mar; 57(3):681-7. PubMed ID: 10199154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.
    Hollenbeck CB; Chen YD; Greenfield MS; Lardinois CK; Reaven GM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):605-8. PubMed ID: 3511084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intensified conventional insulin therapy. The long-term successes and reasons for failure of this therapeutic concept].
    Möhrle W; Richter WO; Schwandt P
    Dtsch Med Wochenschr; 1989 Jun; 114(23):899-902. PubMed ID: 2656186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Asparaginase diabetes mellitus in rabbits: differing effects of two different schedules of L-asparaginase administration.
    Lavine RL; DiCinto DM
    Horm Metab Res; 1984 Dec; 16 Suppl 1():92-6. PubMed ID: 6398268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The biological effect of purely synthetic human insulin in patients with diabetes mellitus].
    Teuscher A
    Schweiz Med Wochenschr; 1979 May; 109(20):743-7. PubMed ID: 451498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus.
    Hughes TA; Gwynne JT; Switzer BR; Herbst C; White G
    Am J Med; 1984 Jul; 77(1):7-17. PubMed ID: 6377892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the transfer of insulin-requiring diabetic patients from U-40 to U-100 Lente insulin.
    Abdulkadir J; Mengistu M; Bekele G
    Ethiop Med J; 1992 Apr; 30(2):105-10. PubMed ID: 1606943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of type 2 diabetes in 2010. Insulins and injectable drugs: role of the general practitioner].
    Renneboog B
    Rev Med Brux; 2010 Sep; 31(4):377-84. PubMed ID: 21089418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative multicenter study of bovine insulin with forms more purified of swine and human insulin in the treatment of type 1 diabetes mellitus].
    Russo EM; Wajchenberg BL; Romaldini JH; Liberman B; Gross JL; Reis LC
    AMB Rev Assoc Med Bras; 1991; 37(2):73-8. PubMed ID: 1658875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source.
    Baldwa VS; Bhandari CM; Pangaria A; Goyal RK
    Ups J Med Sci; 1977; 82(1):39-41. PubMed ID: 20078273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of lipoatrophy with human insulin-therapy.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The U.S. "new patient" and "transfer" studies.
    Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J
    Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferring patients with insulin-dependent diabetes mellitus from animal-source insulins to recombinant DNA human insulin: clinical experience.
    Davidson JK
    Clin Ther; 1989; 11(3):319-30. PubMed ID: 2663162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.